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Summary
In this study, we show that the formation of polyploidy following sustained mitotic checkpoint activation appears to be
preceded by the ubiquitin-dependent proteolysis of hBubR1. In addition, the level of hBubR1 is significantly reduced not
only in polyploid cells created by sustained mitotic spindle damage, but also in 21 (31.3%) of 67 human colon adenocarcino-
mas tested. Importantly, the introduction of hBubR1 triggers the apoptosis of polyploid cells formed by aberrant exit from
mitosis and inhibits the growth of tumors established with these cells in athymic nude mice. These results suggest that
hBubR1-mediated apoptosis prevents the propagation of cells that breach the mitotic checkpoint and that the control of
hBubR1 protein level is an important factor in the acquisition of preneoplastic polyploidy.
Introduction and Cleveland, 2000; Chen, 2002). This “wait anaphase” signal
delays the onset of anaphase by inhibiting the anaphase-pro-
Mitosis is the most dramatic cellular event and requires scrupu- moting complex/cyclosome (APC/C), a multisubunit E3 ubiquitin
lous care of the cell cycle because the segregation of duplicated ligase required for the degradation of securin and the subse-
chromosome pairs during anaphase is an irreversible step. The quent activation of separase, which leads to sister chromatid
mitotic checkpoint maintains the fidelity of this process by sens- separation (King et al., 1996; Nasmyth et al., 2000; Yu, 2002).
ing the proper attachment of microtubules to the kinetochores Recently, a series of elegant studies have documented that
and by monitoring the tension between the kinetochores of APC/C is inhibited through the direct stoichiometric binding of
sister chromatids. The checkpoint uses signal cascades to delay the mitotic checkpoint complex (MCC), containing either BubR1
the onset of anaphase until the kinetochores of each duplicated
(Mad3 in yeast), Bub3, Mad2 and cdc20, or the BubR1-Bub3-
chromosome pair have successfully attached to the spindle
cdc20 and Mad2-cdc20 subcomplexes (Tang et al., 2001; Su-microtubules and are under tension (Biggins and Murray, 1999;
dakin et al., 2001; Millband and Hardwick, 2002; Fang, 2002).Nasmyth et al., 2000; Wassmann and Benezra, 2001). Compo-
Interestingly, the expression of dominant-negative (DN) mutantsnents of the mitotic checkpoint machinery, including Bub1,
of mitotic checkpoint proteins, such as Bub1, not only augmentsBub3, BubR1 (a homolog of yeast Bub1 and Mad3), Mad1,
the formation of polyploidy but also compromises apoptoticMad2, Mad3, Mps1, and the microtubule-dependent motor pro-
cell death in response to spindle damage (Taylor and Mckeon,tein CENP-E, preferentially localize to the kinetochores of un-
1997). This implies that the mitotic checkpoint proteins not onlyaligned chromosomes, where they produce a diffusible “wait
produce the appropriate “wait signal,” but may also execute aanaphase” signal (Taylor and Mckeon, 1997; Taylor et al., 1998;
Waters et al., 1998; Chan et al., 1999; Abrieu et al., 2000; Shah “fail-safe” mechanism whereby cells that breach the mitotic
S I G N I F I C A N C E
Mitotic checkpoint delays the onset of anaphase until all chromosomes are properly attached to the mitotic spindle. After sustained
mitotic arrest, some cells eventually exit mitosis without silencing the mitotic checkpoint. This results in multiploid progeny cells,
which then undergo apoptosis. Thus, apoptosis of these aberrant cells is important for the prevention of chromosomal instability,
such as that observed in human cancers. This study provides evidence that downregulation of the mitotic checkpoint protein hBubR1
is associated with the formation of polyploidy, that hBubR1 functions as a potent apoptotic molecule, and that hBubR1 prevents
abnormal mitotic cells with chromosomal instability from adapting. Consequently, our study provides a clue for elucidating the
functional links between prolonged mitotic checkpoint activation and subsequent apoptotic events.
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Figure 1. Downregulation of hBubR1 protein in
human colorectal adenocarcinoma tissues
Paraffin sections of 67 resected human colon
adenocarcinomas and neighboring normal tis-
sues were probed with monoclonal antibodies
to hBubR1, and visualized with a peroxidase-con-
jugated secondary antibody. Upper panel, rep-
resentative images of normal hBubR1 staining in
a noncancerous epithelial cell layer; lower
panel, representative images of decreased
hBubR1 staining in neoplastic disorganized and
irregular layers of epithelial cells. Epithelial cells
are indicated by arrowhead. Original magnifi-
cation  1,000.
checkpoint are induced to undergo apoptosis rather than be- apoptotic cell death through a p53-independent pathway. How-
ever, a small portion of cells do not undergo apoptosis, insteadcome polyploid.
Defects in the mitotic checkpoint have been proposed to surviving to become polyploid (Minn et al., 1996; Lanni and
Jacks, 1998). This suggested that a study of the functional linkscontribute to the chromosomal instability observed in human
cancers (Lengauer et al., 1998; Masuda and Takahashi, 2002). between mitotic checkpoint signaling and subsequent apoptotic
events might lead to a better understanding of the relationshipIn support of this hypothesis, the depletion or inactivation of
several mitotic checkpoint proteins has been shown to result between the mitotic checkpoint and chromosomal instability in
tumorigenesis.in a loss of checkpoint control and subsequent chromosomal
instability caused by premature anaphase (Li and Benezra, Here, we explore how the defects in the mitotic checkpoint
are derived and adapted during the process of chromosomal1996; Taylor and Mckeon, 1997; Cahill et al., 1998; Gorbsky et
al., 1998; Dobles et al., 2000; Michel et al., 2001). However, instability following sustained mitotic checkpoint activation. We
found that during prolonged mitotic arrest, hBubR1 protein wasthough an impaired mitotic checkpoint is frequently found in
many human cancers, molecular analysis of the genes encoding gradually degraded by ubiquitin-dependent proteolysis and that
this was associated with a concomitant rise in the populationthe mitotic checkpoint proteins in these cancers has revealed
relatively few genetic alterations or changes in the mRNA levels of polyploid cells. Consistent with this observation, hBubR1
protein levels were found to be dramatically reduced in 21(Cahill et al., 1998; Takahashi et al., 1999; Saeki et al., 2002;
Hernando et al., 2001; Haruki et al., 2001; Shichiri et al., 2002; (31.3%) of 67 human colon adenocarcinomas and in polyploid
cells derived by sustained spindle damage. Surprisingly, spe-Masuda and Takahashi, 2002). This raises the possibility that
chromosomal instability in cancers may be due to alterations cific inhibition of hBubR1 degradation and the ectopic expres-
sion of hBubR1 dramatically increased the apoptosis of poly-in the epigenetic control of mitotic checkpoint components at
the protein level. ploid cells that had adapted to prolonged mitotic arrest and
aberrantly exited from mitosis. In addition, we found that adeno-Following prolonged arrest in response to spindle damage,
even cells without known mitotic checkpoint defects eventually virus-directed expression of hBubR1 in athymic mice inhibited
the growth of tumors established with engineered polyploidescape mitotic arrest and exit mitosis in a process called adapta-
tion (Minn et al., 1996; Lanni and Jacks, 1998; Michel et al., cells. Our results suggest that both the stability control and
apoptotic activity of mitotic checkpoint protein hBubR1 may be2001). Though the mechanism of such adaptation is unclear,
cells are likely to arrest in a pseudo-G1 phase and then undergo important in tumorigenesis.
Results
Table 1. Immunohistochemical analysis of hBubR1 expression in 67 human hBubR1 protein levels are reduced in human
colon adenocarcinomas colon adenocarcinomas
Number of Relative It has been well documented that hBubR1, a protein kinase
Expression levels cancer tissues percentagea homologous to Bub1 and Mad3, plays an essential role in the
kinetochore localization of other kinetochore proteins, the bridg-hBubR1 Reduced 21 31.3%
Normal 46 68.7% ing of the kinetochore complex to microtubule through interac-
Total 67 100% tion with CENP-E, and the inhibition of APC activity by binding
a Relative percentage indicates the % of tumor samples having the indi- to Cdc20 (Chan et al., 1999; Wu et al., 2000; Tang et al., 2001;
cated hBubR1 level, as compared to the total number samples, from the Fang, 2002; Chen, 2002). In addition, we observed that the
descriptive study (see Supplemental Figure S1 on the Cancer Cell website). expression of a dominant-negative mutant of hBubR1 in T lym-
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Figure 2. Destabilization of hBubR1 protein during
prolonged mitotic arrest
A: HeLa 229 cells were synchronized by serum
starvation, released for 7 hr, and then cultured
in the presence of nocodazole (Noco, 0.1 g/
ml). At the times indicated, whole cells were har-
vested by scraping and subjected to immu-
noblot analysis with anti-BubR1. The upper and
lower arrowheads indicate hyperphosphory-
lated and hypophosphorylated hBubR1 proteins,
respectively.
B: HeLa 229 cells were also stained with propid-
ium iodide and analyzed by flow cytometry to
determine their DNA content. Mitotic cells, distin-
guished as having 4N or 8N DNA content, are
plotted separately.
C: HeLa 229 cells were synchronized by a double
thymidine block and then cultured in the pres-
ence of either nocodazole (0.1 g/ml) or vincris-
tine (Vin, 5 nM). At the times indicated, cells were
harvested for immunoblotting with the anti-
hBubR1, anti-hMad1, anti-hMad2, or anti-Actin
antibody. The polypeptide corresponding to
each antibody is indicated on the right.
D: Synchronized HeLa 229 cells were exposed to
nocodazole, and the cells were stained with anti-
hBubR1 antibody (green), anti-CENP-C antibody
(red), and Hoechst dye to visualize the DNA
(blue). Interphase cells (I) showed hBubR1 in the
cytoplam. Mitotic cells (M) showed hBubR1 at
the kinetochores. Polyploid cells (P) showed de-
creased hBubR1 staining throughout the cell.
E: Synchronized HeLa 229 cells were exposed to
nocodazole, and the cells were stained with anti-
hBubR1 antibody (red), anti-hMad2 antibody
(green), anti-Cdc20 antibody (green), and
Hoechst dye (blue) as described in D. “I” and
“P” indicate interphase and polyploid cells, re-
spectively.
phocytes compromised apoptotic cell death and mitotic arrest tion from mitosis to interphase (Hershko and Ciechanover, 1998;
Davenport et al., 1999). This suggests that during adaptation toand resulted in increased polyploid formation after prolonged
mitotic spindle damage, implying that hBubR1 activity has far- sustained mitotic arrest, mitotic checkpoint proteins containing
this destruction box motif, such as hBubR1, may be specificallyreaching consequences on cells that breach the mitotic check-
point (Baek et al., 2003). Recently, Davenport and his collabora- degraded by the ubiquitin-proteosome machinery, leading to
the increased formation of polyploid cells and eventual tumori-tors found that hBubR1 and murine BubR1 (mBubR1) contain
the sequence motif (RSTLAELKS), which is consistent with genesis.
To test this possibility, we examined hBubR1 protein levelsknown cyclin destruction sequences that target these proteins
for required ubiquitin-dependent proteolysis during the transi- in 67 human colon adenocarcinomas by immunohistochemical
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Figure 3. Increased stability of hBubR1 protein is associated with reduced polyploidy and increased numbers of apoptotic cells
A: HeLa 229 cells were treated with either DMSO or LLnL (1 g/ml) in the absence (lanes 1 to 3) or presence (lanes 4 to 7) of nocodazole (0.1 g/ml). At
the time points indicated, whole cell lysates were prepared for immunoblotting with an anti-hBubR1 antibody.
486 CANCER CELL : DECEMBER 2003
A R T I C L E
analysis with an anti-hBubR1 antibody. Twenty-one (31.3%) no apparent changes in abundance during the tested time span
(Figure 2C).of the 67 adenocarcinomas studied showed minimal hBubR1
staining in the disorganized and irregular layers of cancerous To rule out the possibility that the observed phenotype re-
sulted from nonspecific effects of nocodazole unrelated toepithelial cells, whereas the neighboring normal tissues showed
intense staining for hBubR1 protein (Figure 1 and Table 1). The checkpoint activation, synchronized HeLa cells were treated
with vincristine, microtubule-inhibiting agent, and analyzed bypercentage of cancers showing reduced hBubR1 protein levels
(31.3%) is much higher than that of cancers harboring mutations immunoblotting. Similar to the case of nocodazole, following
treatment with vincristine, hBubR1 levels decreased over timein mitotic checkpoint genes (Cahill et al., 1998; Saeki et al.,
2002; Hernando et al., 2001; Haruki et al., 2001; Shichiri et al., while hMad2 levels remained consistent (Figure 2C). To confirm
a functional correlation between the hBubR1 protein levels and2002; Masuda and Takahashi, 2002). These results imply that
decrease of hBubR1 protein levels might be a potential mecha- polyploidy, synchronized HeLa cells were treated with nocoda-
zole and the cellular localization of hBubR1 was analyzed bynism for the chromosomal instability associated with tumori-
genesis. immunofluorescence. In interphase cells, the hBubR1 protein
was exclusively localized in the cytoplasm, while in mitotic cells
it was concentrated at the kinetochores (Figure 2D). Far lessProlonged mitotic arrest leads to eventual decrease
hBubR1 protein was seen in polyploid cells, supporting theof hBubR1 levels and a concomitant increase
immunoblot results (Figures 2A and 2C, and see Supplementalin polyploid cells
Figure S2 at http://www.cancercell.org/cgi/content/full/4/6/As hBubR1 is a known mitotic checkpoint protein and levels of
483/DC1). Furthermore, to rule out the possibility that nocoda-hBubR1 are decreased in a number of human adenocarcino-
zole treatment had damaged the kinetochores and renderedmas, we next investigated the connection between hBubR1
them susceptible to degradation and malfunction, we investi-levels and ploidy by examining hBubR1 protein stability during
gated the localizations of other kinetochore-localized proteins,prolonged spindle damage induced by a microtubule-depoly-
i.e., Cdc20, CENP-C, and hMad2, after prolonged mitotic arrestmerizing agent. Synchronized HeLa 229 cells were treated with
(Figures 2D and 2E). HeLa cells were treated with nocodazolenocodazole and harvested at various time points for immu-
and stained with anti-hBubR1, anti-Cdc20, anti-CENP-C, andnoblotting and flow cytometry (Figures 2A and 2B). Consistent
anti-hMad2 antibodies. Interestingly, the expression levels andwith previous reports (Li et al., 1999; Chen, 2002), the phosphor-
kinetochore localizations of CENP-C, Cdc20, and hMad2 wereylation of hBubR1 protein increased rapidly from 6 to 18 hr after
maintained in polyploid cells, whereas hBubR1 was markedlytreatment, as cells progressed through the S and G2 phases
downregulated and detected at only low levels at the kineto-and arrested in mitosis. By 24 hr after nocodazole treatment,
chores.only phosphorylated hBubR1 was detected, and the total
Taken together, these results indicate that the degradationamount of hBubR1 was slightly reduced. Simultaneously, there
of hBubR1 occurred in a specific manner with no apparentwas a significant increase in the population of sub-G1 (2N)
changes in other kinetochore proteins during prolonged mitoticcells, which indicates increased apoptotic cell death. Interest-
arrest. Thus, the stability of this protein might be implicated iningly, by 36 hr after treatment, hBubR1 protein levels had de-
the formation or maintenance of polyploidy, providing a func-creased to undetectable in some cells, among which apoptosis
tional link between hBubR1 degradation and carcinogenesis.was not observed. In addition, the population of polyploid cells
with 8N DNA increased dramatically. These results suggested
that the stability of the hBubR1 protein might be involved in the The formation of polyploidy following mitotic
checkpoint activation might be preceded by theregulation of apoptosis and polyploidy following mitotic check-
point activation. ubiquitin-dependent proteolysis of hBubR1
As shown in Figure 2, hBubR1 protein levels were dramaticallyTo investigate whether the degradation of mitotic check-
point proteins is a general phenomenon following mitotic check- decreased in nocodazole-treated cells, with concomitant in-
creases in the polyploid cell populations. Therefore, we treatedpoint activation, we monitored levels of other mitotic checkpoint
components, i.e., hMad1 and hMad2, during prolonged mitotic HeLa cells with the proteasome inhibitor N-acetyl-L-leucinyl-
L-leucinyl-L-norleucinal (LLnL) to determine whether hBubR1arrest. Under the tested conditions, hBubR1 protein was rapidly
degraded after 36 hr of nocodazole treatment. In contrast, downregulation was due to proteasome-mediated degradation
(Figure 3A, lanes 1 to 3). Regardless of the presence or absencehMad1 and hMad2 proteins were stable for up to 54 hr, showing
B: Synchronized HeLa 229 cells were exposed to nocodazole for 18 hr prior to DMSO or LLnL treatment. At the time indicated on the top, cells were harvested
for immunoblotting with anti-hBubR1.
C: Synchronized HeLa 229 cells were exposed to nocodazole for 18 hr and further cultured in the absence or presence of LLnL (0.5 g/ml). Cells were
harvested and analyzed by flow cytometry.
D: Relative percentages of sub-G1 (2N) and polyploid (8N) populations were derived from the results presented in C, in which cells were treated with
nocodazole and LLnL, both separately and jointly, for 36 hr.
E: HeLa 229 cells were infected with rAd-hBubR1 for 12 hr and then exposed to nocodazole as indicated. Cells were harvested and analyzed by immunoblot-
ting with anti-Myc antibody. The arrowhead indicates phosphorylated hBubR1.
F: Synchronized HeLa 229 cells were exposed to nocodazole for 18 hr and then infected with rAd-hBubR1 (1  106 pfu/ml). Uninfected control and infected
cells were harvested at the time points indicated on top and subjected to immunoblotting analysis with anti-hBubR1 and anti-Actin antibodies.
G: Relative percentages of sub-G1 (2N) and polyploid (8N) populations were derived from the results presented in F, in which cells were exposed to
nocodazole for 18 hr and then infected with rAd-hBubR1 for a further 24 hr.
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of nocodazole, hBubR1 accumulated significantly in cells negative phenotype (Figures 4A and 4B). The parental and
DN-hBubR1 cell lines were synchronized and further culturedtreated with LLnL versus those treated with DMSO as a control.
in the presence of doxycycline and nocodazole. Notably, cellsIn addition, when synchronized HeLa cells were incubated with
expressing DN-hbubR1 showed a dramatic increase in the poly-nocodazole, both hypophosphorylated and hyperphosphory-
ploid cell population after only 24 hr of nocodazole treatment,lated hBubR1 proteins were significantly stabilized by LLnL
in comparison to the parental cell line (Figure 4C). In addition,treatment (Figures 3A, lanes 4 to 7 and 3B). However, even in
cells expressing DN-hBubR1 showed significantly less apo-the presence of LLnL, hBubR1 protein levels dropped after 24
ptotic cell death than the parental cells, which showed largehr, indicating that a second, proteasome-independent pathway
amounts of cell death in response to the microtubule inhibitor.may also degrade the protein at the later stages of prolonged
These results imply that the expression of DN-hBubR1 leadsmitotic arrest. These observations indicate that the destabiliza-
to polyploidy by hindering endogenous hBubR1.tion of hBubR1 is mediated, at least in part, by an ubiquitin-
To further confirm the importance of hBubR1 protein levelsdependent proteasome pathway.
in the formation of polyploidy, we transfected an hBubR1 siRNANext, to determine whether inhibition of the LLnL-sensitive
expression plasmid, which causes the posttranscriptional genehBubR1 degradation pathway can influence apoptosis and poly-
silencing of hBubR1 expression, into HeLa cells and treated theploidy, HeLa cells were treated with nocodazole in combination
cells with nocodazole. We first confirmed the specificity of thewith LLnL (Figures 3C and 3D). Interestingly, treatment with
hBubR1 siRNA by observing that cells transfected with hBubR1nocodazole and LLnL together resulted in greater increases in
siRNA showed concentration-dependent reduction (30 tothe apoptotic population than did treatment with nocodazole
80%) of endogenous hBubR1 protein levels, whereas the controlor LLnL separately. Consistently, the accumulation of polyploid
siRNA had no effect (Figure 4D). Then we examined the func-cells was dramatically reduced in the presence of LLnL with
tional correlation between decreased hBubR1 expression andnocodazole. To test whether the dramatic increase in apoptotic
the frequency of polyploidy. As expected, inhibition of hBubR1cells observed following treatment with nocodazole plus LLnL
expression resulted in a dramatic production of polyploid cellswas due purely to blockage of hBubR1 degradation, we investi-
from 24 to 48 hr after nocodazole treatment (Figures 4E andgated the effects of introducing a recombinant adenovirus ex-
4F). The frequency of polyploid cells in hBuBR1 siRNA-treatedpressing the wild-type protein (rAd-hBubR1WT). During pro-
cells was clearly higher than that in control transfected cells,longed mitotic arrest induced by nocodazole, we examined
and the trend appeared to correlate with hBubR1 protein levels.whether the LLnL-induced increase in apoptosis and decrease
Together, these results confirm that maintenance of hBubR1
in polyploidy was correlated to hBubR1 protein levels. After
levels following mitotic checkpoint activation might be important
dramatically destabilizing hBubR1 by exposing cells to nocoda-
in preventing survival of adapted polyploid cells.
zole (Figure 3B, upper panel, lanes 4 and 5), we induced rAd-
hBubR1WT expression to mimic the condition of hBubR1 stabil- hBubR1 prevents abnormal mitotic cells with
ity and observed the phosphorylation of hBubR1 in response chromosomal instability from adapting by
to spindle damage (Figures 3E and 3F). Thirty-six hours after triggering apoptosis through the activation of caspases
treatment with nocodazole, uninfected control cells showed a Since the exogenous expression of hBubR1 preferentially re-
marked decrease in the levels of hBubR1 (Figure 3F, lanes 4 to duced the population of polyploid cells and increased apopto-
6). In contrast, cells infected with rAd-hBubR1WT revealed sis, as shown in Figure 3G, it is tempting to believe that hBubR1
strong expression of exogenous hBubR1 (Figure 3F, lanes 10 may play a role in triggering apoptosis after aberrant cell exit
to 12). To investigate whether exogenous expression of hBubR1 from mitotic arrest. Thus, to investigate the effect of hBubR1
is associated with a reduction in the polyploid population, we on apoptosis, the protein was introduced into HeLa cells via a
used flow cytometry to analyze changes in the DNA content of Gal4-hBubR1 fusion expression plasmid. Transfectants were
rAd-rBubR1WT-infected cells treated with nocodazole. Impor- cultured in the absence or presence of nocodazole and then
tantly, overexpression of hBubR1 protein was associated with analyzed for apoptosis by TUNEL assay (Figure 5A). Interest-
increased apoptotic cell death and a decreased polyploid cell ingly, exogenous hBubR1 had no apparent proapoptotic activity
population (Figure 3G and see Supplemental Figure S3 on Can- in the absence of nocodazole treatment (), but apoptosis was
cer Cell website). These consequences appear to be similar to clearly induced in hBubR1-overexpressing cells treated with
those induced by treatment with LLnL. In contrast, the popula- nocodazole (). To confirm that the apoptotic cell death is
tion of 4N cells arrested in mitosis was unaffected by the expres- specific to polyploid cells and to exclude the intrinsic effect of
sion of exogenous hBubR1 (data not shown). These results adenoviral vector backbone, HeLa cells were cultured in the
suggest that the degradation of hBubR1 is required for the presence of nocodazole and then infected with either a recombi-
formation of polyploidy and that the restoration of this protein nant adenovirus expressing -galactosidase (rAd-LacZ) or rAd-
augments the susceptibility of polyploidy to apoptotic cell death. hBubR1WT (described above). As expected, rAd-LacZ had no
effect on the cell population profiles compared with uninfected
Targeted inhibition of hBubR1 function cells. In contrast, infection with rAd-hBubR1WT eliminated the
increases polyploidy population of polyploid cells, but not tetraploid cells, and subse-
To investigate whether blockade of hBubR1 affects the acquisi- quently increased apoptotic cell death, supporting the notion
tion of polyploidy, we generated a HeLa cell line expressing a that hBubR1 specifically induces apoptotic cell death of poly-
deletion mutant of hBubR1 (DN-hBubR1) that contained the ploid cells (Figures 5B and 5C).
N-terminal homology domain. This construct localizes to the To elucidate the mechanism by which hBubR1 triggers apo-
kinetochore by binding to kinetochore proteins other than ptotic cell death, HeLa cells were cultured in conditions of serum
starvation or induced toward spindle disruption by nocodazolehBub3 and Cdc20, but should have an otherwise dominant-
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Figure 4. Mutational and posttranscriptional inhibition of hBubR1 leads to increased polyploidy and decreased apoptotic cell death under conditions of
prolonged spindle damage
A: A schematic diagram of wild-type hBubR1 and Myc epitope-tagged dominant-negative (DN) hBubR1 (DN-hBubR1).
B: Kinetochore localization of DN-hBubR1 in mitotic cells. The plasmid encoding DN-hBubR1 was transfected into HeLa cells, which were then treated with
nocodazole (0.2 g/ml) for 24 hr, fixed and stained with anti-hBubR1 (red), anti-Myc (green), and Hoechst dye for DNA visualization (blue).
C: To investigate the effect of DN-hBubR1 expression on mitotic checkpoint regulation, we established a HeLa cell line that expressed DN-hBubR1 under
the control of the tetracycline-responsive promoter. DN-hBubR1-expressing and control HeLa cells were incubated with doxycycline (to induce expression)
and treated with nocodazole. At the time points indicated, the cells were harvested and analyzed by flow cytometry.
D–E: HeLa cells were transiently transfected with 10 g of either the backbone siRNA plasmid as a control or the hBubR1 siRNA expression plasmid and
then exposed to nocodazole (50 ng/ml) 16 hr later. Transfected cells were harvested at the time points indicated on the right and analyzed by immunoblotting
with anti-BubR1 and anti-Actin (D) or flow cytometry (E).
F: Relative percentages of sub-G1 (2N) and polyploid (8N) populations were derived from the flow cytometric analysis in E.
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Figure 5. Overexpression of hBubR1 protein in mitotic cells leads to apoptotic cell death and decreased polyploidy
A: HeLa cells were transfected with Gal4-hBubR1 and cultured in the absence () or presence () of nocodazole (0.1 g/ml). Cells were fixed, treated
with anti-Gal4, and the level of apoptosis was determined by TUNEL assay.
B: HeLa cells were synchronized, exposed to nocodazole for 18 hr, and then infected with rAd-LacZ or rAd-hBubR1 at 5  106 pfu/ml. As a control,
synchronized HeLa cells were also cultured in the absence or presence of nocodazole without adenoviral infection. After being further incubated for 18
hr, uninfected and infected cells were fixed and analyzed by flow cytometry.
C: Relative percentage of sub-G1 (2N) and polyploid (8N) populations.
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treatment, both of which induce an apoptosis-prone status. parental HeLa cells had 2N and 4N in the absence of nocodazole
(Figures 6A and 6B). Data from one clone, HeLa-M3, is de-These cells were then infected with rAd-LacZ or rAd-BubR1WT
and analyzed by immunoblotting with an antibody against cas- scribed here. Interestingly, the treatment of asynchronous pa-
rental (HeLa) and polyploid (HeLa-M3) cells with nocodazolepase-3, an effector caspase in the apoptotic pathway. Caspase-
3 activation was not observed in uninfected cells or those in- resulted in the accumulation of cells with 4N and 8N DNA,
respectively (Figure 6A). However, the growth rate of HeLa-M3fected with rAd-LacZ (Figure 5D, lanes 4 and 6). In contrast,
the levels of procaspase-3, which are inversely correlated with cells was indistinguishable from that of the parental HeLa cells
(data not shown). As previously reported, this instability in thethe activation of this caspase (Shi, 2002), were significantly
reduced in rAd-hBubR1WT-infected cells that had been serum chromosomal number is induced by chromosomal missegrega-
tion and reflects adaptation to a mitotic defect (Lengauer etstarved or treated with nocodazole (Figure 5D, lanes 5 and 7).
In parallel with this observation, the cleaved form of caspase-3, al., 1998). Therefore, established polyploid clones possessing
reduced levels of hBubR1 might be susceptible to the apoptotican indicator of activation, was also dramatically increased in
rAd-hBubR1WT-infected cells. To further address the nature of promoting activity by hBubR1 in vitro and in vivo. Thus, to test
whether the polyploid cell line, HeLa-M3, is a suitable vehiclethe apoptotic pathway induced by hBubR1, HeLa cells were
cultured in the absence or presence of actinomycine D or noco- for the study of the apoptotic potential of hBubR1, we examined
the induction of apoptosis in this cell line by DN-hBubR1 versusdazole, respectively, and infected with rAd-LacZ or rAd-
hBubR1; cells were then immunoblotted with antibodies against that of WT-hBubR1. Cells were cultured and infected with rAd-
LacZ, recombinant adenovirus expressing a dominant-negativecaspase-3, -8, and -9 (Figure 5E). Consistent with the results
shown in Figure 5D, the activation of these caspases was not mutant of hBubR1 (rAd-DN-hBubR1), or rAd-hBubR1WT (Figure
6C). As expected, infection with rAd-DN-hBubR1 or rAd-LacZobserved at any time in uninfected cells or in those infected
with rAd-LacZ (Figure 5E, lanes 1, 2, 4, and 6). However, levels of did not induce apoptosis of HeLa-M3 cells, whereas infection
with rAd-hBubR1WT was sufficient to stimulate apoptosis, indi-procaspase-3 and -9, but not procaspase-8, were significantly
reduced, and the active form of caspase-3 was dramatically cating that this polyploid cell line satisfied our requirements.
These results also suggest that the N-terminal region of hBubR1increased in rAd-hBubR1WT-infected cells treated with actino-
mycin D or nocodazole (Figure 5E, lanes 5 and 7). To further (contained within the DN construct) is not sufficient for the apo-
ptotic activity of hBubR1.confirm these observations, infected cells were exposed to no-
codazole in combination with z-VAD and z-LEHD, which are Next, we investigated whether other mitotic checkpoint pro-
teins are capable of triggering apoptotic cell death (Figures 5Ccell-permeable inhibitors for caspase -3 and -9, respectively
(Figure 5E, lanes 8 and 9). As predicted, pretreatment with z-VAD and 5D). We found that hBub1, but not hBub3, hMad1, or
hMad2, increased the apoptotic cell population in HeLa-M3or z-LEHD inhibited the reduction of procaspase-3 and the in-
duction of active caspase-3 by rAd-hBubR1 infection. cells, but less significantly than did hBubR1 (Figures 6D and
5E). These results were further confirmed by biochemical analy-Taken together, these results suggest that hBubR1 func-
tions as a potent apoptotic molecule through the activation of sis using antibodies against caspase-3 and cIAP-1, an inhibitor
of apoptosis (Figure 6F). As expected, expression of exogenouscaspase-9, an initiator caspase associated with the intrinsic
apoptotic pathway, followed by activation of caspase-3. In addi- hBub1 or hBubR1 augmented the levels of active caspase-3,
but decreased the levels of cIAP-1. Thus, it appears that despitetion, these results also imply that the apoptotic activity of
hBubR1 is facilitated by the activation of the cell cycle check- cooperation between these checkpoint proteins to produce the
signaling for mitotic arrest, their actions are not mutually depen-point, which arrests cells and promotes the apoptosis-prone
state by modulating the levels of other apoptotic proteins such dent. In addition, these results suggest that the different apo-
ptotic potentials of mitotic checkpoint proteins are likely to beas Bcl-2 and Bax.
reflected by different protein stabilities during the acquisition of
polyploidy, as shown in Figure 2.Apoptotic potential of mitotic checkpoint proteins
in established polyploid cells
The above results indicate that the degradation of hBubR1 and Expression of hBubR1 inhibits the growth of polyploid
cell-established tumors in nude micesubsequent loss of apoptotic activity may contribute to the adapta-
tion of cells to prolonged mitotic arrest, leading to the formation Given that the apoptotic potential of hBubR1 appears to monitor
abnormalities in cells that have aberrantly exited from mitoticof polyploidy. Therefore, we next investigated the role of hBubR1
in established polyploid cell clones that avoid apoptotic cell arrest, it is vital to determine whether the expression of hBubR1
suppresses the development of tumors established withdeath after treatment with the spindle-disrupting agent nocoda-
zole. Flow cytometric analysis revealed that nine independent adapted polyploid cells. To directly evaluate the in vivo antitumor
activity of hBubR1, polyploid tumors were established in athymicclones mainly contained 4N and 8N DNA contents, whereas the
D: The activation of caspase-3 by hBubR1 expression is shown. HeLa cells infected with rAd-LacZ or rAd-hBubR1 at 2  106 pfu/ml, as described above,
were either serum starved (lanes 4 and 5) or treated with nocodazole (0.1 g/ml, lanes 6 and 7), harvested, and then subjected to immunoblot analysis
with anti-caspase-3 antibody. (P) and (A) indicate the inactive precursor and active forms of caspase-3, respectively.
E: HeLa cells infected with rAd-Lac Z or rAd-hBubR1 at 2  106 pfu/ml were treated with either actinomycine D (5 nM, lanes 4 and 5), nocodazole (lanes
6 and 7), or a combination of nocodazole and caspase inhibitors (z-VAD and z-LEHD, 25 nM, lanes 8 and 9) and harvested for immunoblotting with anti-
caspase-8, anti-caspase-9, and anti-caspase-3 antibodies, respectively. (P) and (A) indicate the inactive precursor and the active forms of each caspase,
respectively.
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Figure 6. The apoptotic potential of the mitotic checkpoint proteins in established polyploid cells
A: To determine the apoptotic potentials of other mitotic checkpoint proteins, asynchronized HeLa and HeLa-M3 cells were cultured in the absence ()
or presence () of nocodazole for 24 hr, harvested, stained with propidium iodide, and then analyzed by flow cytometry to determine the DNA content.
B: Phase contrast images depicting HeLa and HeLa-M3 cells cultured in the absence of nocodazole. The two images equal in scale.
C: HeLa-M3 cells were infected with recombinant adenovirus expressing LacZ, a dominant-negative mutant hBubR1 (DN-hBubR1) or wild-type hBubR1
(hBubR1WT) at 5  106 pfu/ml. At 24 hr after infection, cells were stained with propidium iodide, and the sub-G1 populations were determined by flow
cytometry. The data shown are representative of three independent experiments.
D–F: HeLa-M3 cells were infected with recombinant adenovirus expressing hBub1, hBub3, hMad1, hMad2, or hBubR1 (D, 5  106 pfu/ml; E, 2  106 pfu/ml)
and then harvested at the times indicated and processed by flow cytometry for determination of their sub-G1 DNA content (D). The relative apoptotic
potentials of these mitotic checkpoint proteins were compared by immunoblotting using anti-caspase-3 and anti-cIAP-1 antibodies (F). (P) and (A) indicate
the inactive precursor and the active forms of caspase-3, respectively. These results were consistent across four different experiments.
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rAd-DN-hBubR1 and those with rAd-LacZ (Figure 7B). Taken
together, these results suggest that hBubR1 may inhibit the
growth of polyploid tumors in vivo.
Discussion
The activation of the mitotic checkpoint requires the precise
timing and spatial organization of mitotic regulatory events. Re-
cently, extensive studies have revealed that the kinetochore
proteins, Bub1-3, BubR1, Mad1-2, Mps1, and CENP-E, monitor
the unattached kinetochore and trigger anaphase inhibition in
the presence of a damaged mitotic spindle or chromosomal
misalignment. However, it is not known how the mitotic check-
point is functionally linked with the apoptotic events following
aberrant cellular exit from mitosis, or with chromosomal instabil-
ity as it relates to tumorigenesis. Our data provide compelling
evidence that the mitotic checkpoint protein BubR1 is not only
a sensor that monitors the mitotic checkpoint, but that it is also
involved in apoptotic signaling and chromosomal instability.
Epigenetic control of mitotic checkpoint
proteins and cancer
It has been shown that mitotic checkpoint dysfunction is caused
by the inactivation of mitotic checkpoint components, which
leads to chromosomal instability by permitting the premature
onset of anaphase (Taylor and Mckeon, 1997; Cahill et al., 1998;
Gorbsky et al., 1998; Dobles et al., 2000; Michel et al., 2001;
Pihan and Doxsey, 2003). However, it remains to be determined
whether the mitotic checkpoint is abrogated during the evolution
of normal cells into precancerous aneuploid cells, and if so,
what causes this loss of mitotic checkpoint function. To date,
a few cancers have been linked to mutational inactivation of
mitotic checkpoint genes, such as members of the MAD and
BUB families (Cahill et al., 1998; Takahashi et al., 1999; Saeki
et al., 2002; Hernando et al., 2001; Haruki et al., 2001; Masuda
and Takahashi, 2002). However, transcripts of these genes ap-
pear to be maintained at similar levels in aneuploid cancer cells
and in neighboring normal cells (Shichiri et al., 2002), suggesting
that mutational inactivation or transcriptional failure of these
checkpoint genes may be responsible for only a small portion
Figure 7. Intratumoral injection with rAd-hBubR1 inhibits the growth of poly- of chromosomally unstable cancers. Although it is possible that
ploid cell-derived tumors in nude mice
mutation or misexpression of members of other gene families
1  108 HeLa-M3 cells were inoculated subcutaneously into the backs of may account for some of these cases, it seems equally likely
female Balb/c athymic nude mice. Tumors were allowed to grow to a size
that changes in mitotic checkpoint protein levels, caused byof about 130 mm3. Animals were then randomized (ten mice per group)
degradation or alterations in posttranslational modification, areand infected four times with rAd-hBubR1 WT (A and B), rAd-DN-hBubR1 (A),
or rAd-LacZ (B) at 5  108 pfu/ml (per dose) intratumorally over a period of responsible for abrogation of the mitotic checkpoint and the
2 weeks. Tumor sizes were measured in three dimensions using a Vernier resulting chromosomal instability.
caliper at three day intervals.
In this work, we found that hBubR1 protein levels are sig-
nificantly reduced in about 30% of human adenocarcinomas,
a higher frequency than found in previous mutational studies.
In addition, the precancerous polyploid cell population beginsnude mice by subcutaneous injection of HeLa-M3 cells. When the
to appear and increases as the hBubR1 protein is graduallytumors reached a volume of about 130 mm3, mice were intratumor-
degraded by ubiquitin-dependent proteolysis after prolongedally infected with rAd-LacZ, -DN-hBubR1, or -hBubR1WT. Animals
spindle damage. After sustained mitotic arrest, there is a sig-infected with the non-apoptosis-inducing rAd-DN-hBubR1
nificant reduction of this protein in arrested cells and a concomi-showed significant tumor growth, with tumors increasing up to
tant increase of polyploidy. In contrast, other mitotic checkpointtwenty times their original size (Figures 7A and 7B). In contrast,
proteins, such as hMad1 and hMad2, do not reflect this trend.tumor growth was markedly suppressed in mice injected with
Furthermore, expression of exogenous hBubR1 in depleted cellsrAd-hBubR1WT. This inhibitory effect continued for up to 39
led to a reduction in the number of polyploid cells, apparentlydays, suggesting that the hBubR1-mediated apoptotic activity
through apoptosis. These results imply that the acquisition ofefficiently prevented tumor progression (Figure 7A). There was
no difference in the rates of tumor growth in mice infected with polyploidy during prolonged mitotic arrest is preceded by the
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degradation of hBubR1, which may be a pathogenic mechanism exit mitosis, and undergo apoptosis. However, a small portion
of these cells escape apoptosis and continue cell cycle progres-contributing to chromosomal instability during tumorigenesis.
However, it remains to be elucidated how the degradation sion, which results in their evolution into polyploid cells (Minn
et al., 1996; Cahill et al., 1998; Lanni and Jacks, 1998; Michelof hBubR1 is triggered after sustained mitotic arrest and which
cellular factors are involved in the degradation of this protein. et al., 2001). However, it is unclear what determines the fate of
these adapted cells. A first clue was provided by a report regard-A variety of findings indicate that ubiquitin-dependent proteoly-
sis is a key event during cellular exit from mitotic arrest and that ing the effect of a dominant-negative mutant of murine Bub1
(N-mBub1) on the checkpoint response to spindle damage (Tay-it is targeted by the degradation of several mitotic component
proteins such as mitotic cyclines and securin (Hershko and lor and Mckeon, 1997). In this study, N-mBub1 compromised
mitotic arrest by checkpoint activation and apoptotic cell deathCiechanover, 1998; Zachariae and Nasmyth, 1999). During mi-
totic arrest in the metaphase, APC/C-mediated proteolysis is in HeLa cells after prolonged spindle damage. We observed
similar results with our targeted inhibition of hBubR1, suggestinginhibited by MCC, which consists of BubR1, Bub3, Mad2, and
cdc20, or the BubR1-Bub3-cdc20 and Mad2-cdc20 subcom- that the mitotic checkpoint is functionally connected with apo-
ptotic events subsequent to adaptation.plexes, indicating that hBubR1 is physically associated with
the multisubunit E3 ubiquitin ligase, APC/C (Tang et al., 2001; In the present study, we verified that hBubR1 triggers the
apoptosis of cells escaping from prolonged mitotic arrest. InSudakin et al., 2001; Fang, 2002). Thus, although we have not
tested whether APC/C and its associated proteins play a role addition, we found that exogenous hBubR1 induces apoptotic
cell death in hBubR1-depleted polyploid cells and inhibits thein the degradation of hBubR1, it is possible that the specificity
of APC/C for its target proteins is eventually deregulated during expansion of tumors established with them in vivo. It also seems
as though the ability of many primary hepatocarcinoma cell linesprolonged mitotic arrest and that this leads to the degradation
of associated proteins, such as hBubR1. The reduced concen- to induce apoptosis in response to prolonged spindle damage
is dependent on the expression levels of hBubR1 protein (Sup-tration of hBubR1 may then cause an imbalanced MCC stoichi-
ometry, leading to a reduced inhibitory capacity for APC/C. plemental Figure S3 on Cancer Cell website). Furthermore, con-
centration-dependent reduction of hBubR1 in MCF-7 breastEventually, this may result in further acceleration of hBubR1
degradation and the premature activation of APC/C, leading to cancer cells appears to correlate with the degree of apoptotic
competence and the frequency of polyploidy (data not shown).cellular exit from the metaphase before all chromosomes are
bi-oriented at the metaphase plate, thus causing chromosomal Together, these results suggest that hBubR1 not only plays an
important role in producing the “wait anaphase” mitotic check-missegregation.
Interestingly, it has been reported that following prolonged point signal, but that it also functions as a proapoptotic effector
in response to premature cellular exit from mitosis with un-mitotic arrest, cells can exit mitosis by the inhibitory phosphory-
lation of Cdc2, instead of relying on degradation of cyclin B aligned chromosomes. Thus, after cells have adapted during
prolonged mitotic arrest, hBubR1 may be an important failsafe(Minshull et al., 1996; Wang and Burke, 1996). This alternative
exit pathway may affect the susceptibility of hBubR1 to ubiqui- responsible for preventing these cells from evolving into poly-
ploid, precancerous cells. Thereby, the undesirable degradationtin-dependent proteolysis by E3 ubiquitin ligases with different
selectivities for APC/C, by the phosphorylation status of Cdc2, of this protein during adaptation allows the formation of poly-
ploidy. As shown in Figure 5, apoptosis induced by hBubR1 isthus leading to activation of APC/C and the premature onset
of anaphase. These possibilities should be further addressed observed under the proapoptotic conditions of cell cycle arrest
in G0 (by serum starvation) or mitosis (by nocodazole treatment).to determine the nature of the correlation between the mitotic
checkpoint and chromosomal instability during tumorigenesis. In addition, hBubR1 induced the apoptotic death of cells ar-
rested at G1 or G2/M after exposure to actinomycin D or irradia-Interestingly, we did not observe alterations in the stabilities
of other checkpoint proteins, such as hMad1 and hMad2, in tion (data not shown). These observations imply that hBubR1
alone is insufficient to induce apoptotic cell death at all stagesresponse to prolonged spindle damage. However, since mitotic
checkpoint proteins may have differentially controlled stabilities, of the cell cycle and that alterations in other components in-
volved in the apoptotic pathway are required. In support of thisdepending on cancer type or host species, the stability or modi-
fication of checkpoint components other than hBubR1 should notion, apoptosis has been shown to involve the harmonized
regulation of proapoptotic genes such as Bax and antiapoptoticbe investigated in a variety of human cancers. Consistent with
this notion, a reduction in Mad2 was observed in breast cancer genes such as Bcl-2. In cells deprived of growth factors or
subjected to genotoxic stresses, such as actinomycin D andcell lines, and experimental reduction of Mad2 in animal models
led to development of cancer (Li and Benezra, 1996; Michel et UV irradiation, p53 is activated and modulates the apoptosis-
related proteins, leading to a proapoptotic status. These condi-al., 2001). While we do not exclude the possibility that a silent
polymorphism in a mitotic checkpoint gene may lead to changes tions seem to facilitate the apoptotic activity of hBubR1. How-
ever, the expression profile of BubR1 showed that this proteinin the biochemical properties or conformational stoichiometry
of some components during tumorigenesis, our results suggest is undetectable in the G1 phase and then peaks in the G2/M
phase (Davenport et al., 1999), indicating that the apoptoticthat epigenetic control of mitotic checkpoint genes might be a
key contributor during cellular adaptation to mitotic defects and activity of hBubR1 might be restricted to mitosis.
chromosomal instability.
Regulation of the apoptotic activity of hBubR1 during
mitosis and after prolonged mitotic arresthBubR1 induces apoptotic cell death in response
to prolonged spindle damage During mitosis, hBubR1 is abundantly expressed and concen-
trated at the kinetochore, but does not induce apoptosis underFollowing prolonged spindle damage, even cells possessing a
competent mitotic checkpoint eventually adapt to mitotic arrest, normal conditions. Notably, survivin, an inhibitor of caspase-9,
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To create the hBubR1 siRNA expression plasmid, siRNA oligonucleo-is highly expressed and localized along the spindle microtubule
tides (5-gatccccaagggttcagagccatcagttcaagagactgatggctctgaaccctttttttggduring the same time period (Li et al., 1998). After prolonged
aaa-3 and 5-agcttttccaaaaaaagggttcagagccatcagtctcttgaactgatggctctgamitotic arrest, aberrant cellular exit from mitosis is caused by
acccttggg-3) were inserted into the pSUPER vector as previously described
the inhibitory phosphorylation of Cdc2, the kinase activity of (Brummelkamp et al., 2002).
which has been shown to increase the stability of survivin or
its affinity for active caspase-9 (O’Connor et al., 2000). These Synchronization and cell cycle analysis
To generate synchronized populations, HeLa cells were arrested at G0 andobservations raise the possibility that the apoptotic activity of
at the G1/S boundary by serum starvation and a double thymidine block,hBubR1 is antagonized by survivin during normal mitosis, but
respectively, as previously described (Taylor and McKeon, 1997). After re-that the inhibitory phosphorylation of Cdc2 by a second exit
lease, cells were treated with medium containing nocodazole. At various
pathway induces not only aberrant cellular exit from mitosis but time points after the nocodazole treatment, cells were harvested, fixed, and
also the degradation of survivin after prolonged mitotic arrest, stained with propidium iodide for flow cytometry analysis. Samples of 10,000
eventually leading to the activation of hBubR1-mediated apo- cells were analyzed for DNA content on a Becton Dickinson FACScan.
ptosis. In support of this hypothesis, we showed that hBubR1
Immunoblot analysis and immunofluorescencetriggers the intrinsic apoptotic pathway upstream of caspase-9,
For immunoblot analysis, cells were synchronized and transfected as abovewhich sequentially activates caspase-3 (Shi, 2002). Thus,
and were then harvested by scraping, washed twice in cold PBS, and lysed.hBubR1-induced apoptosis is likely antagonized by survivin,
Equal amounts of protein (quantitated by Biorad assay) of each sample were
which acts directly on caspase-9 (Ambrosini et al., 1997; O’Con- run on an SDS-PAGE gel, transferred to nitrocellulose filters, blocked, and
nor et al., 2000). In addition, we recently observed that ectopic analyzed with anti-Myc (9E10; Upstate), anti-hBubR1 (Taylor et al., 1998;
BD Pharmingen), anti-CENP-C (Saitoh et al., 1992), anti-Mad1 (kindly sup-expression of hBubR1 induces the release of cytochrome c
plied by Dr. Tim J. Yen), anti-hMad2 (Pharmingen), anti-caspase3 (Santafrom the mitochondrial membrane (unpublished observation),
Cruz), anti-cIAP-1 (Oncogene), or anti-Actin (Santa Cruz).suggesting that Bcl-xL may antagonize the apoptotic activity of
For immunofluorescence, cells were synchronized and infected with thehBubR1. Indeed, this could explain the previous report that
appropriate recombinant adenovirus, cultured on 18 mm coverslips and
overexpression of Bcl-xL augments the polyploid population fixed in 5% formaldehyde for 10 min. Fixed cells were washed, permeabilized
after prolonged mitotic arrest (Minn et al., 1996). Our hypothesis in PBS containing 0.1% Triton X-100, and then incubated with the appro-
priate primary antibody at room temperature for 2 hr. Subsequently, cellsis partially supported by the observation that antiapoptotic
were washed and further incubated with goat anti-mouse IgG conjugatedgenes are overexpressed in many human cancers. However,
with either rhodamine or Cy5 for 1 hr. Cells were washed, exposed tothese possibilities should be further examined, as such investi-
Hoechst dye to visualize the DNA, and viewed under a fluorescence micro-
gations would also aid in understanding the importance of both scope (Zeiss).
the mitotic checkpoint and apoptosis in chromosomal insta- Apoptotic cell death was detected by enzymatic labeling of fragmented
bility. DNA with a TUNEL assay (Roche) according to the manufacturer’s instruc-
tions.In conclusion, the investigation of hBubR1 described here
establishes its novel role in the regulation of apoptosis and
Tissue stainingchromosomal instability and suggests that this protein may be
Sixty-seven human colon adenocarcinoma tissue samples obtained from
a source of new information on the process of tumorigenesis. Seoul National University Medical School were histologically examined using
microsections stained with hematoxylin and eosin. Representative core tis-
Experimental procedures sue biopsies (2 mm in diameter) were taken from formalin-fixed, paraffin-
embedded tumor specimens and arranged in a new recipient paraffin block
Cell lines (tissue array block) using a trephine apparatus (Superbiochips Laboratories).
For generation of polyploid cell lines, HeLa cells were treated with nocoda- Sections were immunostained using the conventional streptavidin-ABC
zole, a microtubule-depolymerizing agent. After 24 hr, cells were washed technique.
and further incubated in nocodazole-free culture media until individual colo-
nies were formed. Because cells treated with nocodazole gradually under- Tumor xenografts on nude mice
went apoptotic cell death, the media (DMEM) were supplemented with cas- To evaluate the ability of rAd-DN-hBubR1, rAd-hBubR1WT, and rAd-LacZ
pase inhibitors to increase colony formation. Colonies were picked, stained (control) to suppress tumor growth in vivo, tumors were formed by subcuta-
with propidium iodide, and analyzed by flow cytometry. neous inoculation of 1 108 HeLa-M3 cells into athymic Balb/c female nude
mice (68 weeks of age; Charles River Laboratories). Tumors were allowed
Plasmid construction and generation to reach a size of about 130 mm3. Animals were then randomized (ten mice
of recombinant adenoviruses per group) and rAd-LacZ, rAd-DN-hBubR1 or rAd-hBubR1WT at 5  108
cDNAs of the mitotic checkpoint proteins, hBub1, hBub3, hMad1, and pfu/ml (per dose) was administered intratumorally four times over a period
hMad2, were amplified by PCR using templates generated by reverse tran- of 2 weeks. Tumor sizes were measured in three dimensions using a Vernier
scription from HeLa cell total mRNA, with oligo-dT as a primer. PCR products caliper at three day intervals.
were then cloned into the pGEM-T easy vector (Promega) for further con-
struction. The plasmid expressing the Gal4-hBubR1 fusion protein was con- Acknowledgments
structed by insertion of the hBubR1 open reading frame into the pCMV-
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